BioNTech/Pfizer (BNT162b2) COVID-19 mRNA vaccine: manufacturing, immunogenicity, efficacy and safety. (2025). Prospects in Pharmaceutical Sciences, 23(1), 31-46. https://doi.org/10.56782/pps.292